Skip to main content
. Author manuscript; available in PMC: 2021 Mar 29.
Published in final edited form as: Pediatr Obes. 2019 Oct 27;15(2):e12581. doi: 10.1111/ijpo.12581

TABLE 2.

Differences in demographics

Overweight Obese Class I Obese Class II Obese Class III P value*
Biochemistry cohort n = 30 n = 169 n = 281 n = 287
Male Sex; n (%) 15 (50%) 90 (53%) 187 (67%) 185 (64%) .015
Hispanic Ethnicity; n (%) 7 (23%) 44 (26%) 64 (23%) 34 (12%) .006
T2DM; n (%) 1 (4%) 11 (7%) 18 (7%) 20 (7%) .920
Vitamin E use; n (%) 0 (0%) 1 (1%) 1 (<1%) 2 (1%) .921
Metformin use; n (%) 1 (3%) 31 (18%) 53 (19%) 71 (25%) .023
Imaging cohort n = 10 n = 74 n = 107 n = 174
Sex (%Male) 4 (40%) 40 (54%) 75 (70%) 122 (70%) .02
T2DM; n (%) 1 (10%) 4/71(6%) 8/98 (8%) 7/163 (4%) .58
Hispanic (n; %) 2 (20%) 20 (27%) 27 (25%) 28 (16%) .39
Metformin (n; %) 4 (40%) 13 (18%) 24 (22%) 35 (20%) .40
Vitamin E use (n; %) 0 (0%) 7 (9%) 5 (5%) 15 (9%) .42
Histology cohort n = 4 n = 48 n = 84 n = 113
Sex (%Male) 3 (75%) 28 (58%) 57 (68%) 78 (69%) .58
T2DM; n (%) 0 (0%) 3 (6%) 9 (11%) 12 (11%) .72
Hispanic (n; %) 2 (50%) 10 (21%) 23 (27%) 19 (17%) .30
Metformin (n; %) 0 (0%) 16 (33%) 24 (29%) 31 (28%) .54
Vitamin E use (n; %) 0 (0%) 3 (6%) 2 (2%) 5(4%) .70

Note. Exact Chi-square tests were used for variables with at least one cell less than 5 in the frequency table. Otherwise asymptomatic Chi-square test was used. Percentages reflect the % within each weight subgroup unless otherwise noted.